A carregar...

The results of an Open, Randomized Comparative Clinical Study to Assess the Reactogenicity, Safety and Immunogenicity of the Vaccine EntseVir in Children Aged 3 to 17 Years

In 2011 - 2012 years in the Institute of childhood infections followed by an open comparative randomized study of tick-borne encephalitis vaccine EntseVir («Microgen») at a dose of 0.25 ml of the two schemes, planned and emergency in children aged 3 - 17 years. As a reference drug used vaccine FSME-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: S. M. Kharit, A. A. Ruleva, I. V. Fridman, E. P. Nacharova, L. A. Alekseeva, G. A. Vasil'eva, A. A. Vilnic, M. V. Ivanova
Formato: Artigo
Idioma:Russo
Publicado em: Numikom LLC 2015-04-01
Colecção:Эпидемиология и вакцинопрофилактика
Assuntos:
Acesso em linha:https://www.epidemvac.ru/jour/article/view/40
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!